SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038597
Filing Date
2020-08-10
Accepted
2020-08-10 07:20:59
Documents
64
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20200630.htm   iXBRL 10-Q 3056099
2 EX-3.1 sage-ex31_289.htm EX-3.1 132391
3 EX-10.1 sage-ex101_204.htm EX-10.1 21705
4 EX-31.1 sage-ex311_8.htm EX-31.1 9346
5 EX-31.2 sage-ex312_7.htm EX-31.2 9282
6 EX-32.1 sage-ex321_6.htm EX-32.1 8650
7 GRAPHIC gh2ikrztch2p000001.jpg GRAPHIC 33727
  Complete submission text file 0001564590-20-038597.txt   9680871

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA sage-20200630.xsd EX-101.SCH 52033
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20200630_cal.xml EX-101.CAL 43031
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20200630_def.xml EX-101.DEF 199006
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20200630_lab.xml EX-101.LAB 404847
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20200630_pre.xml EX-101.PRE 322226
13 EXTRACTED XBRL INSTANCE DOCUMENT sage-10q_20200630_htm.xml XML 1809790
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 201087069
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences